Our firm advised a national health insurance provider and health services company on possible Medicare Part D bid implications due to the Inspector General’s proposed rebate safe harbor rule.
February 2019
Health Services Company Navigates Drug Rebate Rule
North America - United States | North America
Lead Contacts
